Published in Vaccine Weekly, July 25th, 2001
The meeting will be divided into four discrete sections, of five to eight papers each: 1) post-genomic HTP antibody research and development, 2) novel targets and selection, 3) monoclonal antibody generation, and 4) preclinical/clinical progress. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly